The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

CASR  -  calcium-sensing receptor

Homo sapiens

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of CASR

 

Psychiatry related information on CASR

 

High impact information on CASR

  • In addition, the HIFalpha transcriptional activation function is modulated further by asparagine hydroxylation by FIH (factor-inhibiting HIF), which affects recruitment of the coactivators p300 and CBP [7].
  • We demonstrate that mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT), two inherited conditions characterized by altered calcium homeostasis [8].
  • In a few syndromes, tissue selectivity arises from mutation in the open reading frame of a regulatory gene (CASR, TSHR) with selective expression driven by its promoter [9].
  • Missense mutations have been identified in the coding region of the extracellular calcium-sensing receptor (CASR) gene and cause human autosomal dominant hypo- and hypercalcemic disorders [10].
  • In vitro transcription of exon 7 of the CASR containing the Alu sequence yielded the full-length mutant product and an additional shorter product that was truncated due to stalling of the polymerase at the poly(T) tract [10].
 

Chemical compound and disease context of CASR

  • Extracellular Ca(2+) and 1,25(OH)(2)D(3) are potential candidates involved in regulating CaSR expression in the colon and the chemopreventive actions of Ca(2+) and 1,25(OH)(2)D(3) in colon cancer may be mediated, in part, through the CaSR [11].
  • This article describes a patient with ADH due to a gain-of-function mutation in the CaSR, L125P, associated with a Bartter-like syndrome that is characterized by a decrease in distal tubular fractional chloride reabsorption rate and negative NaCl balance with secondary hyperaldosteronism and hypokalemia [12].
  • Changes in calcium concentration were induced by an infusion of disodium-EDTA or calcium in 2 members of a family suffering from hypocalciuric hypercalcaemia ( FHH ) associated with interstitial lung disease [13].
  • This study investigated involucrin staining patterns in fibrous inflammatory hyperplasia of oral mucous membrane (FIH) [14].
 

Biological context of CASR

  • The CASR A986S polymorphism is a likely candidate locus for genetic predisposition to various bone and mineral disorders in which extracellular calcium concentrations have a prominent part [15].
  • METHODS: We genotyped the CASR A986S variant (S allele frequency of 16.3%) in 163 healthy adult women and tested samples of their serum for total calcium, albumin, total protein, creatinine, phosphate, pH, and parathyroid hormone [15].
  • The CASR, a cell surface glycoprotein expressed in parathyroid gland and kidney, is critical for maintaining extracellular calcium homeostasis [1].
  • Mutagenesis of some, but not all, of the potential kappaB elements in the 5' part of the CASR gene led to loss of responsiveness to cytokine [2].
  • Four haplotypes were defined on the basis of CASR gene SNP: haplotype 1 was characterized by the most frequent sequence; haplotypes 2, 3, or 4 by the presence of a single polymorphic variant at codon 986, 990, or 1011, respectively [16].
 

Anatomical context of CASR

  • The CASR has an N-terminal, 19 amino acid signal peptide that is predicted to direct the nascent polypeptide chain, as it emerges from the ribosome, into the endoplasmic reticulum (ER) [1].
  • Here, we show in vivo in the rat that parathyroid, thyroid, and kidney CASR mRNA and protein increased after injection of interleukin-1beta [2].
  • The calcium-sensing receptor (CASR), expressed in parathyroid chief cells, thyroid C-cells, and cells of the kidney tubule, is essential for maintenance of calcium homeostasis [17].
  • Roles of Ca2+ and the Ca2+-sensing receptor (CASR) in the expression of inducible NOS (nitric oxide synthase)-2 and its BH4 (tetrahydrobiopterin)-dependent activation in cytokine-stimulated adult human astrocytes [18].
  • No germ-line mutation of the MEN1 gene was detected in three pedigrees of familial pituitary adenoma and three cases of FIHP [19].
 

Associations of CASR with chemical compounds

  • Sequence analysis demonstrated, in addition to the already described A986S polymorphism, a novel heterozygous G--> A substitution in CASR exon 5 that causes an arginine to glutamine substitution at codon 465 (R465Q) [20].
  • Treatment of these same cells with a calcimimetic, NPS-R-568, augments the CaSR response to Ca(2+), increasing phosphatidylinositol turnover and ERK1/2 phosphorylation, and overcoming the autoantibody effects [21].
  • These results suggest that extracellular Ca(2+) and the CaSR may function to regulate the differentiation of colonic epithelial cells and that disruption of this ligand receptor system may contribute to abnormal differentiation and malignant progression [22].
  • The Ca(2+)-sensing receptor (CaSR) belongs to the class III G-protein-coupled receptors (GPCRs), which include receptors for pheromones, amino acids, sweeteners, and the neurotransmitters glutamate and gamma-aminobutyric acid (GABA) [23].
  • PCR-single strand conformation polymorphism and sequencing revealed that both the proband and the father had a novel heterozygous mutation in CaSR gene that causes lysine to asparagine substitution at codon 47 (K47N), which is in the extracellular domain of CaSR, like 6 of 11 known activating mutations [24].
 

Physical interactions of CASR

  • Our CaSR model should facilitate the development of novel drugs of this important therapeutic target and the identification of the molecular determinants involved in the binding of allosteric modulators of class 3 G-protein-coupled receptors [25].
  • However, the magnesium binding site responsible for inhibition of PTH secretion is not identical with the extracellular ion binding site of the CaSR, because the magnesium deficiency-dependent signal enhancement was not altered on CaSR receptor mutants with increased or decreased affinity for calcium and magnesium [26].
 

Regulatory relationships of CASR

  • Our findings also suggest that CaSR signaling may act via both Gq and Gi to inhibit PTH secretion [21].
  • Also, osteocalcin, a calcium-binding protein highly expressed in bone, dose-dependently stimulated GPRC6A activity in the presence of calcium but inhibited the calcium-dependent activation of CASR [27].
  • Neonatal severe hyperparathyroidism results from homozygosity for inactivating mutations in the CASR gene [28].
  • Direct sequencing of the polymerase chain reaction product showed that the first patient was heterozygous for an already reported inactivating mutation of CaSR (P55L) [29].
 

Other interactions of CASR

  • We investigated 32 families with FIHP to determine the frequency of occult mutation in HRPT2, the gene causing HPT-JT [30].
  • The CaSR allows regulation of parathyroid hormone (PTH) secretion and renal tubular calcium reabsorption in response to alterations in extracellular calcium concentrations [31].
  • BACKGROUND: The regulation of extracellular calcium concentration by parathyroid hormone is mediated by a calcium-sensing, G-protein-coupled cell-surface receptor (CASR) [15].
  • A significant correlation was found between CASR expression and the Ki-67 proliferation index [3].
  • Activating mutations in the CASR gene have been described in autosomal dominant hypoparathyroidism and familial hypocalcemia [32].
 

Analytical, diagnostic and therapeutic context of CASR

References

  1. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia. Pidasheva, S., Canaff, L., Simonds, W.F., Marx, S.J., Hendy, G.N. Hum. Mol. Genet. (2005) [Pubmed]
  2. Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements. Canaff, L., Hendy, G.N. J. Biol. Chem. (2005) [Pubmed]
  3. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. Haven, C.J., van Puijenbroek, M., Karperien, M., Fleuren, G.J., Morreau, H. J. Pathol. (2004) [Pubmed]
  4. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. Mittelman, S.D., Hendy, G.N., Fefferman, R.A., Canaff, L., Mosesova, I., Cole, D.E., Burkett, L., Geffner, M.E. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  5. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Lorentzon, M., Lorentzon, R., Lerner, U.H., Nordström, P. Eur. J. Endocrinol. (2001) [Pubmed]
  6. Role identity and job satisfaction of community health nurses. Laffrey, S., Dickenson, D., Diem, E. International journal of nursing practice. (1997) [Pubmed]
  7. Proline hydroxylation and gene expression. Kaelin, W.G. Annu. Rev. Biochem. (2005) [Pubmed]
  8. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Pollak, M.R., Brown, E.M., Chou, Y.H., Hebert, S.C., Marx, S.J., Steinmann, B., Levi, T., Seidman, C.E., Seidman, J.G. Cell (1993) [Pubmed]
  9. Hereditary hormone excess: genes, molecular pathways, and syndromes. Marx, S.J., Simonds, W.F. Endocr. Rev. (2005) [Pubmed]
  10. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Bai, M., Janicic, N., Trivedi, S., Quinn, S.J., Cole, D.E., Brown, E.M., Hendy, G.N. J. Clin. Invest. (1997) [Pubmed]
  11. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Chakrabarty, S., Wang, H., Canaff, L., Hendy, G.N., Appelman, H., Varani, J. Cancer Res. (2005) [Pubmed]
  12. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. Vargas-Poussou, R., Huang, C., Hulin, P., Houillier, P., Jeunemaître, X., Paillard, M., Planelles, G., Déchaux, M., Miller, R.T., Antignac, C. J. Am. Soc. Nephrol. (2002) [Pubmed]
  13. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. Auwerx, J., Demedts, M., Bouillon, R. Acta Endocrinol. (1984) [Pubmed]
  14. The immunohistochemical detection of involucrin in denture induced fibrous inflammatory hyperplasia of oral mucous membrane. Thomas, G.A. Australian prosthodontic journal / Australian Prosthodontic Society. (1991) [Pubmed]
  15. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Cole, D.E., Peltekova, V.D., Rubin, L.A., Hawker, G.A., Vieth, R., Liew, C.C., Hwang, D.M., Evrovski, J., Hendy, G.N. Lancet (1999) [Pubmed]
  16. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. Vezzoli, G., Tanini, A., Ferrucci, L., Soldati, L., Bianchin, C., Franceschelli, F., Malentacchi, C., Porfirio, B., Adamo, D., Terranegra, A., Falchetti, A., Cusi, D., Bianchi, G., Brandi, M.L. J. Am. Soc. Nephrol. (2002) [Pubmed]
  17. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. Canaff, L., Hendy, G.N. J. Biol. Chem. (2002) [Pubmed]
  18. Roles of Ca2+ and the Ca2+-sensing receptor (CASR) in the expression of inducible NOS (nitric oxide synthase)-2 and its BH4 (tetrahydrobiopterin)-dependent activation in cytokine-stimulated adult human astrocytes. Dal Pra, I., Chiarini, A., Nemeth, E.F., Armato, U., Whitfield, J.F. J. Cell. Biochem. (2005) [Pubmed]
  19. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. Tanaka, C., Yoshimoto, K., Yamada, S., Nishioka, H., Ii, S., Moritani, M., Yamaoka, T., Itakura, M. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  20. Identification of a novel inactivating R465Q mutation of the calcium-sensing receptor. Leech, C., Lohse, P., Stanojevic, V., Lechner, A., Göke, B., Spitzweg, C. Biochem. Biophys. Res. Commun. (2006) [Pubmed]
  21. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Makita, N., Sato, J., Manaka, K., Shoji, Y., Oishi, A., Hashimoto, M., Fujita, T., Iiri, T. Proc. Natl. Acad. Sci. U.S.A. (2007) [Pubmed]
  22. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Chakrabarty, S., Radjendirane, V., Appelman, H., Varani, J. Cancer Res. (2003) [Pubmed]
  23. Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. Silve, C., Petrel, C., Leroy, C., Bruel, H., Mallet, E., Rognan, D., Ruat, M. J. Biol. Chem. (2005) [Pubmed]
  24. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. Okazaki, R., Chikatsu, N., Nakatsu, M., Takeuchi, Y., Ajima, M., Miki, J., Fujita, T., Arai, M., Totsuka, Y., Tanaka, K., Fukumoto, S. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  25. Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. Petrel, C., Kessler, A., Dauban, P., Dodd, R.H., Rognan, D., Ruat, M. J. Biol. Chem. (2004) [Pubmed]
  26. Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits. Quitterer, U., Hoffmann, M., Freichel, M., Lohse, M.J. J. Biol. Chem. (2001) [Pubmed]
  27. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. Pi, M., Faber, P., Ekema, G., Jackson, P.D., Ting, A., Wang, N., Fontilla-Poole, M., Mays, R.W., Brunden, K.R., Harrington, J.J., Quarles, L.D. J. Biol. Chem. (2005) [Pubmed]
  28. Three inherited disorders of calcium sensing. Pollak, M.R., Seidman, C.E., Brown, E.M. Medicine (Baltimore) (1996) [Pubmed]
  29. Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia. Fukumoto, S., Chikatsu, N., Okazaki, R., Takeuchi, Y., Tamura, Y., Murakami, T., Obara, T., Fujita, T. Diagn. Mol. Pathol. (2001) [Pubmed]
  30. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. Simonds, W.F., Robbins, C.M., Agarwal, S.K., Hendy, G.N., Carpten, J.D., Marx, S.J. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  31. Diseases associated with the extracellular calcium-sensing receptor. Thakker, R.V. Cell Calcium (2004) [Pubmed]
  32. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Janicic, N., Soliman, E., Pausova, Z., Seldin, M.F., Rivière, M., Szpirer, J., Szpirer, C., Hendy, G.N. Mamm. Genome (1995) [Pubmed]
  33. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism. Wystrychowski, A., Pidasheva, S., Canaff, L., Chudek, J., Kokot, F., Wiecek, A., Hendy, G.N. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  34. Parathyroid surgery in familial hyperparathyroid disorders. Carling, T., Udelsman, R. J. Intern. Med. (2005) [Pubmed]
 
WikiGenes - Universities